Profile photo

Gastrointestinal Cancers With Zev Wainberg, MD

Gastroenterology

Dr. Wainberg is an academic medical oncologist at the David Geffen UCLA School of Medicine specializing in gastrointestinal malignancies. He currently serves as the co-director of the GI oncology program, medical director of the Pancreas Cancer Center with a joint appointment in medicine and surgery, and as the director of the Early Phase Clinical Research Program at the Jonsson Comprehensive Cancer Center at UCLA. 

Noninvasive Biomarkers for the Early Detection of Pancreatic Cancer Presented at ASCO GI 2025
Dear readers,
We had several updates on trials in pancreas cancer come out yesterday.
First, an update became available on the JCOG1901 trial in pancreas neuroendocrine tumors with randomized data being presented with the combination of lanreotide and everolimus and the impact on survival. We also had discussion on long-term survival in patients who are frail and elderly as defined in the ECOG Giant study.
In addition, an updated educational lecture was presented on the use of investigational non-invasive techniques being assessed in pancreas cancer. We also got a preview of new bi-specifics and immunotherapy modalities in pancreas cancer by Dr. Eileen O’Reilly.
Kindly, Zev Wainberg, MD
Articles